20,240
Participants
Start Date
September 22, 2023
Primary Completion Date
July 31, 2024
Study Completion Date
July 31, 2024
Blood pressure
The first anti-hypertensive prescribed will be categorized as ACEi, ARB, thiazide diuretic, loop diuretic, beta-blocker, calcium channel blocker, other, and none; secondary analyses will combine ACEi and ARB into a single RAAS blocker category. We will conduct additional secondary analyses for specific medications with sufficient sample sizes.
Urine protein
Evaluating urine protein for children with CKD and hypertension is another guideline recommendation, but the frequency, type of assessment (qualitative or quantitative urine protein), and utility for patients without hypertension are unclear. We will determine whether urine protein is evaluated at each encounter and create a dichotomous indicator.
Children's Hospital of Philadelphia, Philadelphia
Collaborators (1)
Patient-Centered Outcomes Research Institute
OTHER
Children's Hospital Medical Center, Cincinnati
OTHER
Ann & Robert H Lurie Children's Hospital of Chicago
OTHER
Nationwide Children's Hospital
OTHER
Seattle Children's Hospital
OTHER
Stanford University
OTHER
University of Colorado, Denver
OTHER
Duke University
OTHER
University of North Carolina, Chapel Hill
OTHER
Indiana University
OTHER
Medical College of Wisconsin
OTHER
University of Iowa
OTHER
Johns Hopkins University
OTHER
University of Michigan
OTHER
University of Florida
OTHER
University of Miami
OTHER
University of Pennsylvania
OTHER
Alfred I. duPont Hospital for Children
OTHER
Children's Hospital of Philadelphia
OTHER